Elevated serum levels of GPX4, NDUFS4, PRDX5, and TXNRD2 as predictive biomarkers for castration resistance in prostate cancer patients: an exploratory study

By sjmartinez • February 4, 2025

Wang R, Wang S, Mi Y, Huang T, Wang J, Ni J, Wang J, Yin J, Li M, Ran X, Fan S, Sun Q, Tan SY, Phillip Koeffler H, Ding L, Chen YQ, Feng N. Elevated serum levels of GPX4, NDUFS4, PRDX5, and TXNRD2 as predictive biomarkers for castration resistance in prostate cancer patients: an exploratory study. Br J Cancer. 2025 Feb 3. doi: 10.1038/s41416-025-02947-0. Epub ahead of print. PMID: 39900986.

Tags: Cedars Sinai DoM, Hematology/Oncology, Publications

PRIME 2.0: An Update to The Proposed Requirements for Cardiovascular Imaging-Related Machine Learning Evaluation Checklist

Kagiyama N, Tokodi M, Hathaway QA, Arnaout R, Davies R, Dey D, Duchateau N, Fraser AG, Goto S, Jamthikar AD, Lam CSP, Oikonomou EK, Ouyang[...]

Patient and Caregiver Outcomes of Health System, Community-Based, and Usual Dementia Care: A Prespecified Analysis of the Dementia Care Study (D-CARE) Randomized Clinical Trial

Reuben DB, Stevens AB, Gill TM, Williamson J, Volpi E, Lichtenstein ML, Jennings LA, Galloway R, Summapund J, Araujo K, Bass D, Weitzman L, Tan[...]

Reply to Letter on “Sex-Specific Trends and Demographic vs Epidemiologic Drivers of Alcohol-Related Cirrhosis in the U.S., 2021-2040”

Danpanichkul P, Diaz LA, Arab JP, Singal AG, Yang JD. Reply to Letter on "Sex-Specific Trends and Demographic vs Epidemiologic Drivers of Alcohol-Related Cirrhosis in[...]